Robert J. Mayer, M.D., Dana-Farber Cancer Institute (IMAGE)
Caption
Research led by scientists at Dana-Farber Cancer Institute showed a new drug combination lengthened the lives of patients with metastatic colorectal cancer, all of whom had exhausted available standard treatments.
Credit
Dana-Farber Cancer Institute
Usage Restrictions
None
License
Licensed content